Episode 26: Chris Min, CMO and Interim CEO at Longeveron, Inc.

Episode 26 • December 07, 2022 • 00:39:02
Episode 26: Chris Min, CMO and Interim CEO at Longeveron, Inc.
Few & Far Between: How Biotech Gets Built
Episode 26: Chris Min, CMO and Interim CEO at Longeveron, Inc.

Dec 07 2022 | 00:39:02

/

Show Notes

"Try to find the people who have a really strong background in regulatory science, who really understand the fundamentals, and who you believe can think creatively about the challenges of the cell therapy space." - Chris Min, Longeveron

Biorasi welcomes Chris Min to the Few & Far Between podcast for an inside look at the cell therapy industry and the importance of finding the right team to support your clinical trials. 

Other Episodes

Episode 46

January 15, 2025 • 00:43:29
Episode Cover

Episode 46: Ben Olds and Amy Fenollosa, Haven Human Asset Ventures

"There's that old saying, 'culture is how people behave when nobody's looking.' So, if you want to be effective, your [mission and value statements]...

Listen

Episode 58

August 14, 2025 • 00:44:43
Episode Cover

Episode 58: Jerry McLaughlin, CEO and Board Member at Life Biosciences

How does a biopharma background prepare you for the biotech playground? Find out in our latest episode of the Biorasi Few & Far Between...

Listen

Episode 21

June 23, 2022 • 00:36:29
Episode Cover

Episode 21: Jill Hawkins, Founder and President of the FAM177A1 Research Fund

How do you start in building a rare disease foundation? Biorasi's Few & Far Between Podcast Welcomes Jill Hawkins, Founder and President of the...

Listen